Skip to main content
OpenTrials
Completed

NCT Number: NCT07545161

Pulsed US Versus SWD in Carpal Tunnel Syndrome

The goal of this clinical trial is to compare two physical therapy treatments in people with mild-to-moderate carpal tunnel syndrome (CTS). CTS is a condition that causes pain, numbness, and weakness in the hand.

The main question this study aims to answer is:

Does pulsed ultrasound or pulsed shortwave diathermy lead to greater improvement in symptoms and nerve swelling when added to standard treatment?

All participants will receive standard conservative treatment, including a wrist splint and nerve and tendon gliding exercises for three weeks. In addition, participants will be randomly assigned to receive one of the following treatments:

Pulsed therapeutic ultrasound (US) Pulsed shortwave diathermy (SWD) Researchers will measure changes in hand symptoms, pain levels, grip strength, and the size of the median nerve using ultrasound imaging. Assessments will be performed before treatment, and at 1 month and 3 months after treatment.

The primary outcome of the study is the change in median nerve cross-sectional area at 3 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kahramanmaras Sutcu Imam University, Kahramanmaraş, Turkey (Türkiye)

Loading trial locations.

About this study

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy of the upper extremity and is characterized by pain, numbness, and hand weakness. Conservative treatment is recommended as first-line therapy in patients with mild-to-moderate CTS and commonly includes wrist splinting and nerve and tendon gliding exercises. Physical therapy modalities are frequently added to improve clinical outcomes.

This randomized, assessor-blinded, parallel-group clinical trial was conducted between March 2025 and Sep 2025. Forty participants with electrophysiologically confirmed mild-to-moderate CTS were randomly assigned to one of two intervention groups. All participants received standard conservative treatment consisting of neutral-position wrist splinting and tendon-nerve gliding exercises for three weeks.

In addition to standard treatment, one group received pulsed therapeutic ultrasound (US) and the other group received pulsed shortwave diathermy (SWD), administered in 15 sessions over three weeks.

Outcome measures were assessed at baseline, 1 month, and 3 months. The primary outcome was the change in median nerve cross-sectional area measured by ultrasonography at 3 months. Secondary outcomes included symptom severity and functional status assessed by the Boston Carpal Tunnel Questionnaire (BCTQ), pain intensity measured by the Visual Analog Scale (VAS), neuropathic pain assessed using the DN4 questionnaire, and hand grip strength measured with a dynamometer.

The study was designed to compare the clinical and structural effects of pulsed US and pulsed SWD when added to standard conservative treatment in mild-to-moderate CTS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 65 years
  • Symptom duration of at least 4 weeks
  • Diagnosis of mild-to-moderate carpal tunnel syndrome confirmed by electromyography

Exclusion criteria

  • Cervical radiculopathy
  • Brachial plexopathy
  • Thoracic outlet syndrome
  • Previous carpal tunnel surgery
  • Severe carpal tunnel syndrome
  • Pregnancy
  • Malignancy
  • Coagulation disorders
  • Cardiac pacemaker
  • Physical therapy for carpal tunnel syndrome within the previous 6 months

Treatment and study plan

Pulsed Therapeutic Ultrasound

Device

Pulsed therapeutic ultrasound was applied to the volar aspect of the wrist using a frequency of 3 MHz, an intensity of 0.8 W/cm², and a pulse ratio of 1:4 for 5 minutes per session. A total of 15 treatment sessions were administered over three weeks.

Pulsed Shortwave Diathermy

Device

Pulsed shortwave diathermy was applied with electrodes positioned parallel to the volar and dorsal aspects of the wrist, centered at the distal palmar crease. Treatment was delivered in pulsed mode at a frequency of 80 Hz and a mean output power of 19.2 W for 15 minutes per session. A total of 15 sessions were administered over three weeks.

Primary outcomes

  1. Change in Median Nerve Cross-Sectional Area (MNCSA)

    Time frame: Baseline and 3 months

    Change in ultrasonographically measured median nerve cross-sectional area (mm²) from baseline to 3 months after treatment.

Secondary outcomes

  1. Change in Boston Carpal Tunnel Questionnaire Score

    Time frame: Baseline, 1 month, and 3 months

    Change in Boston Carpal Tunnel Questionnaire total score (including Symptom Severity and Functional Status subscales) from baseline to 1 month and 3 months after treatment. Higher scores indicate worse symptom severity and functional impairment.

  2. Change in Pain Intensity (VAS)

    Time frame: Baseline, 1 month, and 3 months

    Change in pain intensity measured by a 10-cm VAS, where 0 indicates no pain and 10 indicates worst imaginable pain, from baseline to 1 month and 3 months.

  3. Change in Neuropathic Pain Score (DN4)

    Time frame: Baseline, 1 month, and 3 months

    Change in neuropathic pain severity measured by the DN4 questionnaire (0-10 scale), from baseline to 1 month and 3 months. Higher scores indicate greater neuropathic pain severity.

  4. Change in Grip Strength

    Time frame: Baseline, 1 month, and 3 months

    Change in hand grip strength measured using a hydraulic hand dynamometer (kg), from baseline to 1 month and 3 months.

Sponsors and collaborators

Lead sponsor

Kahramanmaras Sutcu Imam University

Other

Registry information

Official study title

Pulsed Ultrasound Versus Pulsed Shortwave Diathermy in Mild-to-Moderate Carpal Tunnel Syndrome: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 22, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.